Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Mullins

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Cancer Immunology Research|September 4, 2014
BRAF inhibition alleviates immune suppression in murine autochthonous melanomaShannon M Steinberg, Peisheng Zhang, Brian T Malik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Sequential immune escape and shifting of T cell responses in a long-term survivor of melanomaGalina V Yamshchikov, David W Mullins, Chien-Chung Chang, et al.
Oncoimmunology|February 6, 2018
Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapyMark Bazett, Amanda M Costa, Momir Bosiljcic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 11, 2012
Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallengeJason R Baird, Katelyn T Byrne, Patrick H Lizotte, et al.
Melanoma Research|March 15, 2016
The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cellsChery A Whipple, Andrea Boni, Jan L Fisher, et al.
Cancer Immunology, Immunotherapy : CII|August 15, 2016
Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastasesIleana S Mauldin, Nolan A Wages, Anne M Stowman, et al.
Frontiers in Medicine|August 6, 2019
Novel Microbial-Based Immunotherapy Approach for Crohn's DiseaseSimon Sutcliffe, Shirin Kalyan, Jim Pankovich, et al.
Cancer Immunology, Immunotherapy : CII|August 15, 2016
Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastasesIleana S Mauldin, Nolan A Wages, Anne M Stowman, et al.
Nature Communications|May 22, 2019
LNK suppresses interferon signaling in melanomaLing-Wen Ding, Qiao-Yang Sun, Jarem J Edwards, et al.
Science Translational Medicine|February 18, 2021
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responsesJennifer A Lo, Masayoshi Kawakubo, Vikram R Juneja, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Cancer Immunology Research|September 4, 2014
BRAF inhibition alleviates immune suppression in murine autochthonous melanomaShannon M Steinberg, Peisheng Zhang, Brian T Malik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Sequential immune escape and shifting of T cell responses in a long-term survivor of melanomaGalina V Yamshchikov, David W Mullins, Chien-Chung Chang, et al.
Oncoimmunology|February 6, 2018
Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapyMark Bazett, Amanda M Costa, Momir Bosiljcic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 11, 2012
Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallengeJason R Baird, Katelyn T Byrne, Patrick H Lizotte, et al.
Melanoma Research|March 15, 2016
The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cellsChery A Whipple, Andrea Boni, Jan L Fisher, et al.
Cancer Immunology, Immunotherapy : CII|August 15, 2016
Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastasesIleana S Mauldin, Nolan A Wages, Anne M Stowman, et al.
Frontiers in Medicine|August 6, 2019
Novel Microbial-Based Immunotherapy Approach for Crohn's DiseaseSimon Sutcliffe, Shirin Kalyan, Jim Pankovich, et al.
Cancer Immunology, Immunotherapy : CII|August 15, 2016
Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastasesIleana S Mauldin, Nolan A Wages, Anne M Stowman, et al.
Nature Communications|May 22, 2019
LNK suppresses interferon signaling in melanomaLing-Wen Ding, Qiao-Yang Sun, Jarem J Edwards, et al.
Science Translational Medicine|February 18, 2021
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responsesJennifer A Lo, Masayoshi Kawakubo, Vikram R Juneja, et al.
Pageof 4